CDSCO Panel denies Nacto Pharma's request To Waive Phase III CT of Anticancer Erdafitinib tablet Dr. Divya Colin13 Aug 2023 6:00 PM ISTNew Delhi: Rejecting the waiver of Phase III clinical trial proposal for Erdafitinib Tablets 3mg, 4mg, and 5mg, the Subject Expert Committee (SEC)...
Alembic pharma's Proposal for Azithromycin to prevent maternal infection rejected by CDSCO panel Dr. Divya Colin12 Aug 2023 6:00 PM ISTNew Delhi: Citing that the data was not adequate, the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization...
Troikaa's Paracetamol IM injection 250mg/ml Exempted from price control: NPPA Dr. Divya Colin11 Aug 2023 6:00 PM ISTNew Delhi: Noting that Troikaa Pharmaceutical's formulation "Paracetamol Injection Intramuscular (IM) 250mg/ml, 2ml" was duly approved by the Office...
Retail prices of 44 formulations fixed by NPPA Ruchika Sharma10 Aug 2023 12:31 PM ISTNew Delhi: National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 44 formulations including those indicated for the treatment of...
Trademark Infringement Suit: Delhi HC awards Rs 5 lakh cost to Sun Pharma over Oxiplat mark Farhat Nasim9 Aug 2023 6:51 PM ISTNew Delhi: Ruling in favour of Sun Pharmaceuticals Ltd. (Sun Pharma), Delhi High Court has awarded costs of Rs 5 lakh to the drug giant in a trademark...
Do not submit same batch no. of cough syrup to two different laboratories: DCGI tells Manufacturers, Exporters Dr. Divya Colin8 Aug 2023 6:00 PM ISTNew Delhi: Safeguarding public health, through a recent notification, the Drug Controller General of India (DCGI) has notified all drug manufacturers'...
CDSCO Panel Rejects Dr. Reddy's Proposal For Ketorolac Tromethamine plus Serratiopeptidase FDC Dr. Divya Colin7 Aug 2023 6:00 PM ISTNew Delhi: Citing there is no rationality data, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Conduct Bioequivalence Study: CDSCO panel tells Abbott India on Dydrogesterone MR Tablets Dr. Divya Colin6 Aug 2023 6:00 PM ISTNew Delhi: Responding to the proposal for manufacturing and marketing synthetic progesterone, Dydrogesterone Modified-release (MR) Tablets presented...
Conduct bioequivalence study: CDSCO Panel Tells Cipla on Arsenic Trioxide Oral Solution Dr. Divya Colin5 Aug 2023 6:00 PM ISTNew Delhi: In response to a proposal presented by drug major Cipla for manufacturing and marketing of the chemotherapeutic agent Arsenic Trioxide Oral...
'Honey' Trap? Dabur clarifies on presence of cancer causing chemicals in product, says report motivated, baseless Farhat Nasim4 Aug 2023 7:33 PM ISTNew Delhi: Terming the claim as "motivated" and "baseless", Dabur India Ltd has junked the report about the presence of cancer-causing substance in...
Lupin Gets CDSCO Panel Nod To study osteoporosis drug Denosumab Dr. Divya Colin4 Aug 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Mansukh Mandaviya calls for mandatory adoption of Good Manufacturing Practices by all pharma companies Ruchika Sharma3 Aug 2023 3:30 PM ISTObservations from ongoing risk-based inspections further reiterated the need to have a re-look at the current GMP regulations and quality management...
